The study confirms the usefulness of Paxlovid as an early-stage treatment to prevent hospitalization for COVID-19
Johns Hopkins’ ARISE program may increase the likelihood of home discharge for hospitalized COVID-19 patients
Prevalence and clinical outcomes of viral and bacterial co-infections in hospitalized COVID-19 patients